Tower Research Capital (TRC)’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58K | Buy |
40,592
+33,317
| +458% | +$47.6K | ﹤0.01% | 2839 |
|
|
2025
Q1 | $11.6K | Sell |
7,275
-3,699
| -34% | -$5.92K | ﹤0.01% | 3520 |
|
|
2024
Q4 | $39.5K | Sell |
10,974
-12,722
| -54% | -$45.8K | ﹤0.01% | 2710 |
|
|
2024
Q3 | $135K | Buy |
23,696
+1,852
| +8% | +$10.6K | ﹤0.01% | 1990 |
|
|
2024
Q2 | $101K | Buy |
21,844
+14,931
| +216% | +$69K | ﹤0.01% | 2574 |
|
|
2024
Q1 | $56.5K | Sell |
6,913
-9,409
| -58% | -$76.9K | ﹤0.01% | 2190 |
|
|
2023
Q4 | $92.2K | Buy |
16,322
+4,063
| +33% | +$23K | ﹤0.01% | 2711 |
|
|
2023
Q3 | $22.8K | Buy |
12,259
+2,877
| +31% | +$5.35K | ﹤0.01% | 3259 |
|
|
2023
Q2 | $25.8K | Buy |
9,382
+5,546
| +145% | +$15.3K | ﹤0.01% | 3140 |
|
|
2023
Q1 | $12K | Buy |
3,836
+2,339
| +156% | +$7.32K | ﹤0.01% | 4055 |
|
|
2022
Q4 | $9K | Sell |
1,497
-8,603
| -85% | -$51.7K | ﹤0.01% | 4168 |
|
|
2022
Q3 | $89K | Buy |
10,100
+7,268
| +257% | +$64K | ﹤0.01% | 2655 |
|
|
2022
Q2 | $21K | Sell |
2,832
-8,204
| -74% | -$60.8K | ﹤0.01% | 3729 |
|
|
2022
Q1 | $268K | Buy |
11,036
+6,209
| +129% | +$151K | ﹤0.01% | 1529 |
|
|
2021
Q4 | $155K | Buy |
4,827
+2,003
| +71% | +$64.3K | ﹤0.01% | 1950 |
|
|
2021
Q3 | $126K | Buy |
2,824
+1,680
| +147% | +$75K | ﹤0.01% | 2202 |
|
|
2021
Q2 | $44K | Sell |
1,144
-932
| -45% | -$35.8K | ﹤0.01% | 3122 |
|
|
2021
Q1 | $76K | Buy |
2,076
+1,790
| +626% | +$65.5K | ﹤0.01% | 2793 |
|
|
2020
Q4 | $9K | Buy |
+286
| New | +$9K | ﹤0.01% | 4372 |
|